We serve Chemical Name:5-(4-iodophenyl)-2-propan-2-ylpyrazol-3-amine CAS:1017781-38-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-(4-iodophenyl)-2-propan-2-ylpyrazol-3-amine
CAS.NO:1017781-38-2
Synonyms:5-(4-iodo-phenyl)-2-isopropyl-2h-pyrazol-3-ylamine;3-(4-iodophenyl)-1-isopropyl-1h-pyrazol-5-amine
Molecular Formula:C12H14IN3
Molecular Weight:327.16400
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:43.84000
Exact Mass:327.02300
LogP:3.89900
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-(4-iodo-phenyl)-2-isopropyl-2h-pyrazol-3-ylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(4-iodophenyl)-1-isopropyl-1h-pyrazol-5-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(4-iodophenyl)-1-isopropyl-1h-pyrazol-5-amine Use and application,5-(4-iodo-phenyl)-2-isopropyl-2h-pyrazol-3-ylamine technical grade,usp/ep/jp grade.
Related News: Grégoire then joined telecoms service provider Cirpack, following its acquisition of Andrexen, as Chief Marketing and Product Officer. He most recently held the position of Chief Strategy Officer at Experty.io, a blockchain-based knowledge sharing platform. Reductase, nitrate (acceptor) (uncultured soil bacterium clone D142gene narG fragment) manufacturers When these modified cells are given back to the patient, they are transported in the bloodstream to the bone marrow where they start to make healthy red blood cells that produce beta-globin. The effects of Zynteglo are expected to last for the patient’s lifetime. trans-α-Aethyl-2-methoxy-5-methyl-α’-n-propylstilben suppliers For skin rash, the difference in response rates for anifrolumab versus placebo at week 52 were 13.5% SLE Disease Activity Index (SLEDAI), 15.5% British Isles Lupus Assessment Group index (BILAG) and 15.6% modified Cutaneous Lupus Erythematosus Disease Area and Severity Index (mCLASI). For arthritis, differences in response rates were 8.2% SLEDAI, 11.8% BILAG and 12.6% joint response. 6-methyl-9-(1-methylethyl)bicyclo[4.3.0]nona-2,9-diene-1-carbonyl(dimethyl)phenylsilane vendor & factory.
